| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President and COO | President and CEO
4 companies
Daniel N Swisher Jr. is President and CEO at VIRX and has filed Form 4s across 4 companies. From February 2015 to October 2025, the filings on record show 5 open-market purchases and 39 sales. Daniel N Swisher Jr.'s net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $13.1M at current prices.
Historically, Daniel N Swisher Jr.'s trades have earned a below-average insider score of 48/100 across 35 rated trades. Over a 12-month horizon, 27.3% of those trades were profitable, with an average 12-month return of -35.3%.
The biggest single holding is JAZZ (~$12.6M) as President and COO.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2020 | CERS Cerus Corp | Director | Buy | 1,000 | $4.15 | $4,150.00 | +2.2% | |
| Aug 25, 2015 | VIRX Viracta Therapeutics, Inc. | President and CEO | Buy | 25,000 | $1.01 | $25,250.00 | +14.3% | |
| Jul 24, 2015 | VIRX Viracta Therapeutics, Inc. | President and CEO | Sell | 12,715 | $3.46 | $43,974.83 | -7.8% | |
| Jul 24, 2015 | VIRX Viracta Therapeutics, Inc. | President and CEO | Buy | 25,000 | $1.02 | $25,457.50 | +16.7% |